Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (33)
Sumit Gupta
Division of Haematology–Oncology, University of Toronto, Toronto
Rachel E. Rau
Seattle Children’s Hospital, Seattle
John A. Kairalla
Department of Biostatistics, Colleges of Medicine, Public Health, and Health Professions, University of Florida, Gainesville
Karen R. Rabin
Cindy Wang
Department of Biostatistics, Colleges of Medicine, Public Health, and Health Professions, University of Florida, Gainesville
Anne L. Angiolillo
Servier Pharmaceuticals, Boston
Sarah Alexander
Division of Haematology–Oncology, University of Toronto, Toronto
Andrew J. Carroll
Department of Genetics, University of Alabama at Birmingham, Birmingham
Susan Conway
Department of Biostatistics, Colleges of Medicine, Public Health, and Health Professions, University of Florida, Gainesville
Lia Gore
Ilan Kirsch
Adaptive Biotechnologies, Seattle
Holly R. Kubaney
Children’s Blood and Cancer Center and Dell Children’s Medical Center of Central Texas, Austin
Amanda M. Li
British Columbia Children’s Hospital, University of British Columbia, Vancouver
Jennifer L. McNeer
Division of Pediatric Hematology–Oncology, University of Utah, Primary Children’s Hospital, Salt Lake City
Olga Militano
Children’s Oncology Group, Monrovia, CA
Tamara P. Miller
Department of Pediatrics, Emory University School of Medicine, Atlanta
Yvonne Moyer
Biopathology Center and Children’s Oncology Group Biospecimen Bank, Nationwide Children’s Hospital, Columbus, OH
Maureen M. O’Brien
Children’s Hospital Colorado and the University of Colorado School of Medicine, Aurora
Maki Okada
Department of Pediatric Hematology–Oncology, MemorialCare Miller Children’s and Women’s Hospital Long Beach, Long Beach, CA
Shalini C. Reshmi
Steve and Cindy Rasmussen Institute for Genomic Medicine and the Biopathology Center, Nationwide Children’s Hospital, Columbus, OH
Mary Shago
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto
Elizabeth Wagner
Biopathology Center and Children’s Oncology Group Biospecimen Bank, Nationwide Children’s Hospital, Columbus, OH
Naomi Winick
Department of Pediatrics, Division of Pediatric Hematology–Oncology, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas
Brent L. Wood
Department of Pathology and Laboratory Medicine, Children’s Hospital of Los Angeles, Los Angeles
Tara Haworth-Wright
Seattle Children’s Hospital, Seattle
Faraz Zaman
Amgen, Thousand Oaks, CA
Gerhard Zugmaier
Amgen Research, Munich, Germany
Sue Zupanec
Division of Haematology–Oncology, University of Toronto, Toronto
Meenakshi Devidas
Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN
Stephen P. Hunger
Department of Pediatrics and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia
David T. Teachey
Elizabeth A. Raetz
Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York
Mignon L. Loh
Seattle Children’s Hospital, Seattle